+ All Categories
Home > Documents > TREATMENT OF SMALL VEINS

TREATMENT OF SMALL VEINS

Date post: 30-Dec-2015
Category:
Upload: desiree-becker
View: 34 times
Download: 3 times
Share this document with a friend
Description:
TREATMENT OF SMALL VEINS. SENTARA COSMETIC AND LASER TREATMENT CENTER. CHRISTI SILER, R.N. Examples of Small Veins. Etiology of Venous Disease. Heredity- Primary cause Pregnancy Obesity Standing or sitting for long periods of time Trauma Incidence- 80% female & 20% male. - PowerPoint PPT Presentation
26
www.sentara.com 8/31/08 1 TREATMENT OF SMALL VEINS CHRISTI SILER, R.N. SENTARA COSMETIC AND LASER TREATMENT CENTER
Transcript

www.sentara.com

8/31/08 1

TREATMENT OF SMALL VEINS

CHRISTI SILER, R.N.SENTARA COSMETIC AND LASER TREATMENT CENTER

www.sentara.com

8/31/08 2

Examples of Small Veins

www.sentara.com

8/31/08 3

Etiology of Venous Disease

• Heredity- Primary cause

• Pregnancy

• Obesity

• Standing or sitting for long periods of time

• Trauma

• Incidence- 80% female & 20% male

www.sentara.com

8/31/08 4

Microanatomy of Venous System

Spider Veins

Reticular Vein

Perforator

www.sentara.com

8/31/08 5

Algorithm for Small Vessel Treatment

• Rule out truncal insufficiency- plan to correct if present

• Determine system involved

• Identify associated reticular veins

• Perform appropriate treatment

• Compression for 5-7 days

• Follow-up & re-treat in 4-6 weeks

www.sentara.com

8/31/08 6

Lateral Reticular Vein with associated telangiectasia

www.sentara.com

8/31/08 7

Small Vein Treatment Options

• Sclerotherapy- still the Gold Standard

• Lasers- great adjunct to treatment

• Non lasers- IPL, Ohmic Thermolysis, Vascutouch

• Microphlebectomy- for large reticular veins

• Combination Therapy- BEST OPTION for quickest and cosmetically superior results

www.sentara.com

8/31/08 8

The Ideal Sclerosant

• Non-allergenic/ Non-toxic

• Painless• No risk of

hyperpigmentation• No risk of telangiectatic

matting• No ulceration• FDA approved

• UNFORTUNATELY, no sclerosant meets all of this criteria

www.sentara.com

8/31/08 9

Detergent Properties

• Efficient sclerosant- causes intimal inflammation thrombus formation fibrous tissue vein obliteration

• Painless

• Low rate of allergies

• Low rate of pigmentation

• Extravasation tolerated at low amounts

www.sentara.com

8/31/08 10

Reticular Veins

• R/O truncal insufficiency/ incompetent perforators

• Inject reticular veins first

• Follow with laser/ sclerotherapy to telangiectasias

• Compression dressing post tx facilitates clotting

www.sentara.com

8/31/08 11

Why Combination Therapy?

Vessel damage d/t heat

Laser spider veins first

Decreased intimal lumen

Less sclerosant neededLower incidence of hyperpigmentation

TWICE THE DAMAGE MEANS TWICE AS FAST!

www.sentara.com

8/31/08 12

Lasers- Not All are Created Equal

• 940 nm and 1064 nm most common for treatment of telangiectasias

• Goal is to cause vessel damage without damaging surrounding tissue

• No sun exposure or sunless tanning prior to tx

• Test laser and sclerotherapy at consultation to assess response and candidacy for treatment

www.sentara.com

8/31/08 13

Superior Cosmetic Result with Combination Therapy

www.sentara.com

8/31/08 14

www.sentara.com

8/31/08 15

Foam Sclerotherapy

• CO2 vs. Room Air– CO2 bubbles dissolves faster in arterial

circulation, thus reducing the risk of adverse event

• Tessari Method-– 1 part solution: 4 parts

gas– Stopcock, 2 syringes

www.sentara.com

8/31/08 16

Foam Sclerotherapy

www.sentara.com

8/31/08 17

•Advantages-•Increases surface area of sclerosant, thus reducing amount

of drug needed

•Circumferential contact with intimal wall causes more damage/

better result

•Displaces blood, thus avoiding dilution of drug/ increases efficacy

•Disadvantages-•Patients with PFO may not be candidate

•Neurological deficits-•Migraine•Scotoma

•DVT- clear deep system with foot dorsiflexion immediately post tx and encourage ambulation

www.sentara.com

a

8/31/08 18

www.sentara.com

8/31/08 19

Before/ After Foam Sclerotherapy

www.sentara.com

6 Weeks After One Treatment!

8/31/08 20

www.sentara.com

8/31/08 21

www.sentara.com

Facial Telangiectasias

8/31/08 22

www.sentara.com

Adverse Sequelae

• Post Sclerotherapy Hyperpigmentation- transient

• Localized Urticaria d/t inflammatory response/ histamine release

• Angiogenesis/ Telangiectatic Matting- R/O truncal insufficiency or perforators to decrease risk

• Discomfort at injection site

• Recurrence- hereditary8/31/08 23

www.sentara.com

Complications

• Cutaneous necrosis

• Superficial thrombophlebitis

• DVT

• Nerve Injury

• Allergic Reaction

• Migraine

• Scotoma

8/31/08 24

www.sentara.com

8/31/08 25

www.sentara.com

In Summary• Reticular veins & associated telangiectasia can be

easily treated in the office setting

• R/O truncal insufficiency or incompetent perforators

• Microphlebectomy if needed for large reticular veins

• Laser/ RF first and follow with sclerotherapy

• Foam sclerotherapy to reticular veins if appropriate candidate

• Dilute sclerotherapy to telangiectasia

• Most patients require 3-5 treatments spaced 4-6 weeks apart for optimal results

8/31/08 26


Recommended